Mengrong Yan

机构：Guangzhou Experimental Station · ORCID：0000-0003-0093-2775

发表论文 9 篇 · 总被引 63 次 · h-index 4

代表论文

• Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein (2024 · Signal Transduction and Targeted Therapy · 被引 28)
• The Key Roles of Mycobacterium tuberculosis FadD23 C-terminal Domain in Catalytic Mechanisms (2023 · Frontiers in Microbiology · 被引 11)
• Crystal structure of the apurinic/apyrimidinic endonuclease IV from Mycobacterium tuberculosis (2018 · Biochemical and Biophysical Research Communications · 被引 9)
• Structural characterization of the HCoV-229E fusion core (2018 · Biochemical and Biophysical Research Communications · 被引 9)
• Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus (2026 · PLoS Pathogens · 被引 2)
• Identification of broad-spectrum M pro inhibitors: a focus on high-risk coronaviruses and conserved interactions (2025 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 1)